Diarrhea News and Research

Latest Diarrhea News and Research

International community observes World Water Day

U.N. Deputy Secretary-General Jan Eliasson on Thursday "launched a call for urgent action to end the crisis of 2.5 billion people without basic sanitation, and to change a situation in which more people worldwide have mobile phones than toilets," the U.N. News Centre reports (3/21).

25 Mar 2013

Trained Spanish nurses provide quality care comparable to that of general practitioners, study finds

A new study has found that Spanish nurses trained specifically to resolve acute health problems of low complexity provide care of comparable quality to that of general practitioners. Published early online in the Journal of Advanced Nursing, the findings suggest that nurses may be able to take on some of the care generally provided by physicians.

21 Mar 2013

Positive results from Affinium Pharmaceuticals' Phase 2a clinical trial of AFN-1252 in ABSSSI

Affinium Pharmaceuticals announced today that its Phase 2a clinical trial evaluating oral AFN-1252 in acute bacterial skin & skin structure infections demonstrated excellent efficacy and safety data, marking a significant proof-of-concept milestone for Affinium's first-in-class, novel antibiotic targeted against bacterial fatty acid biosynthesis inhibition (FabI inhibitors).

21 Mar 2013

Study examines overuse of ER for nonemergency visits

Visits to the ER are not always for true medical emergencies - and some policymakers have been fighting the problem by denying or limiting payments if the patient's diagnosis upon discharge is for "nonemergency" conditions.

21 Mar 2013

ProtiDiet High Protein Chocolate Dream Bars may contain Salmonella, warns FDA

Pro-Amino International Inc. is recalling protein bars which may contain Salmonella. The product is the ProtiDiet High Protein Chocolate Dream Bar, sold in 210 gram (7.4 oz.) packages, 7 bars per package, bearing UPC 6 21498 42238 1, lot code CR 18 13B, and Best Before date of 2015-08.

19 Mar 2013

Global efforts to address malnutrition should factor in immunization

"On Red Nose Day, we are reminded of the famine in Ethiopia that triggered the first Comic Relief, over 25 years ago," and "as we reflect, we now know that the link between malnutrition and infectious disease makes for a particularly vicious circle," Seth Berkley, CEO of the GAVI Alliance, writes in an opinion piece in the Guardian's "Global Development Professionals Network."

19 Mar 2013

Probiotics help stress-associated gastrointestinal disorders, study says

For those with irritable bowel syndrome who wonder if stress aggravates their intestinal disorder, a new University of Michigan Health System study shows it's not all in their head.

15 Mar 2013

Study: Contaminated water used to dilute pesticides could be source of human norovirus

Human norovirus, also known as the winter vomiting bug, is one of the most common stomach bugs in the world. The virus is highly contagious, causing vomiting and diarrhea, and the number of affected cases is growing.

14 Mar 2013

Investigational treatment for ulcerative colitis (UC) and Crohn’s disease (CD) has Marketing Authorisation Application submitted

Takeda Pharmaceutical Company Limited (“Takeda”) today announced that a Marketing Authorisation Application (MAA) has been submitted to The European Medicines Agency (EMA) for vedolizumab, an investigational, gut-selective humanized monoclonal antibody for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn’s disease (CD), the two most common types of inflammatory bowel disease (IBD).

8 Mar 2013

More than 60% of fire ant allergic patients do not adhere to treatment guidelines

Two million Americans are allergic to insect stings, an allergy which sends more than 500,000 people to the emergency room annually. Yet, according to a study published today in the March issue of Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAA), while fire ant allergy sufferers know allergy shots can save their life, more than 60 percent do not adhere to treatment guidelines.

4 Mar 2013

Amoxicillin effectiveness: an interview with Prof Paul Little, University of Southampton

Amoxicillin is a broad spectrum penicillin, and in the UK is one of the most frequently used antibiotics. It is commonly used either on its own or, where there are particular concerns about resistance, in combination as Co-amoxiclav (as Amoxicillin-clavulanic acid) which extends its anti-bacterial spectrum.

1 Mar 2013

Poor sanitation in Africa causing hundreds of thousands of deaths, WaterAid report says

"Poor sanitation is causing hundreds of thousands of deaths a year in Africa, where 600 million people -- about 70 percent of the population -- do not have a safe toilet," and that number is up from 210 million in 1990 and continues to increase as the population grows and people move into poor urban areas, according to a report from WaterAid, titled "Keeping promises: why African leaders need now to deliver on their past water and sanitation commitments," the Guardian reports.

1 Mar 2013

Cubist receives FDA QIDP designation for ceftolozane/tazobactam to treat HABP/ VABP, cUTI

Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has designated the company's late-stage antibiotic candidate, ceftolozane/tazobactam, as a Qualified Infectious Disease Product (QIDP) for the indications of Hospital-Acquired Bacterial Pneumonia (HABP)/Ventilator-Associated Bacterial Pneumonia (VABP) and Complicated Urinary Tract Infections (cUTI).

1 Mar 2013

Scientists identify two populations of human cells that migrate to the intestine

Researchers at Wake Forest Baptist Medical Center and colleagues have identified a special population of adult stem cells in bone marrow that have the natural ability to migrate to the intestine and produce intestinal cells, suggesting their potential to restore healthy tissue in patients with inflammatory bowel disease (IBD).

28 Feb 2013

Taiho Pharmaceutical seeks Japanese approval for TAS-102 to treat colorectal cancer

Taiho Pharmaceutical Co., Ltd. announced on February 27 that it submitted an application on February 26 for approval of the manufacture and marketing of the novel oral nucleoside antitumor agent TAS-102 (combination of trifluorothymidine (FTD) and tipiracil hydrochloride (TPI)) to the Japanese Ministry of Health, Labor and Welfare.

27 Feb 2013

Complementary medicine risks: an interview with Dr Andrew Boyden, NPS MedicineWise

Complementary medicines include products containing herbs, vitamins, minerals, nutritional supplements, homoeopathic medicines, certain aromatherapy products and traditional Chinese medicines. For this reason they are also called herbal, natural or alternative medicines.

26 Feb 2013

Bayer receives FDA approval for Stivarga to treat advanced gastrointestinal stromal tumors

The U.S. Food and Drug Administration today expanded the approved use of Stivarga (regorafenib) to treat patients with advanced gastrointestinal stromal tumors (GIST) that cannot be surgically removed and no longer respond to other FDA-approved treatments for this disease.

26 Feb 2013

NIAID-funded Phase I trial to evaluate two related candidate vaccines against shigellosis

Researchers have launched an early-stage human clinical trial of two related candidate vaccines to prevent infection with Shigella, bacteria that are a significant cause of diarrheal illness, particularly among children.

21 Feb 2013

Vaccine prices and availability: an interview with Kate Elder, Vaccines Policy Advisor for Médecins Sans Frontières's Access Campaign

One of the key reasons why children are missed by immunization programs, particularly in developing countries where Médecins Sans Frontières (MSF) works, is that the products that we currently have in their present formulation are not well-suited to the places that have the most un-immunized children. These are the most challenging contexts to work in.

19 Feb 2013

Study identifies regions of genes linked to Beh-et's disease

Researchers don't know the exact cause of Beh-et's disease, a chronic condition that leads to oral and genital sores and serious complications such as blindness, but new research brings better understanding to what makes some people more susceptible to being affected.

16 Feb 2013

Diarrhea News and Research

Latest Diarrhea News and Research

International community observes World Water Day

Trained Spanish nurses provide quality care comparable to that of general practitioners, study finds

Positive results from Affinium Pharmaceuticals' Phase 2a clinical trial of AFN-1252 in ABSSSI

Study examines overuse of ER for nonemergency visits

ProtiDiet High Protein Chocolate Dream Bars may contain Salmonella, warns FDA

Global efforts to address malnutrition should factor in immunization

Probiotics help stress-associated gastrointestinal disorders, study says

Study: Contaminated water used to dilute pesticides could be source of human norovirus

Investigational treatment for ulcerative colitis (UC) and Crohn’s disease (CD) has Marketing Authorisation Application submitted

More than 60% of fire ant allergic patients do not adhere to treatment guidelines

Amoxicillin effectiveness: an interview with Prof Paul Little, University of Southampton

Poor sanitation in Africa causing hundreds of thousands of deaths, WaterAid report says

Cubist receives FDA QIDP designation for ceftolozane/tazobactam to treat HABP/ VABP, cUTI

Scientists identify two populations of human cells that migrate to the intestine

Taiho Pharmaceutical seeks Japanese approval for TAS-102 to treat colorectal cancer

Complementary medicine risks: an interview with Dr Andrew Boyden, NPS MedicineWise

Bayer receives FDA approval for Stivarga to treat advanced gastrointestinal stromal tumors

NIAID-funded Phase I trial to evaluate two related candidate vaccines against shigellosis

Vaccine prices and availability: an interview with Kate Elder, Vaccines Policy Advisor for Médecins Sans Frontières's Access Campaign

Study identifies regions of genes linked to Beh-et's disease

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Diarrhea News and Research

Latest Diarrhea News and Research

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Newsletters you may be interested in